UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	November 23, 2021

Accession Number:	0001213900-21-060083
Submission Type:	POS AM
CIK: 0001601936 Company Name: Altamira Therapeutics Ltd. File Number: 333-237907